Since over 60% of the ME/CFS cohort reported an infectious trigger (Table 1), we expanded the previous characterization of NK cells in ME/CFS cases and healthy controls by analyzing the potential biomarker value of the CD57 expression with NKp46 or NKG2C. The gene discussed is NCR1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.